|
variable
|
Univariate OR (95% CI)
|
P-value
|
Mutivariate OR (95% CI)
|
P-value
|
|---|
|
Nosocomial versus HCA
| | | | |
|
≤ 1
|
6.160 (2.668–14.224)
|
0.000
|
5.665 (2.277–14.092)
|
0.000
|
|
2–10
|
7.040 (2.203–22.497)
|
0.001
|
5.332 (1.506–18.870)
|
0.009
|
|
11–18
|
24.640 (2.894–209.815)
|
0.003
|
18.772 (2.09–168.583)
|
0.009
|
|
19–59
|
1.384 (0.766–2.502)
|
0.282
|
1.308 (0.699–2.445)
|
0.401
|
|
Diabetes mellitus
|
0.037 (0.187–0.948)
|
0.037
|
0.609 (0.249–1.487)
|
0.276
|
|
Hematological malignancy
|
2.425 (1.287–4.570)
|
0.006
|
1.882 (0.686–5.166)
|
0.220
|
|
Brain tumor
|
3.052 (1.124–8.284)
|
0.029
|
3.411 (1.139–10.215)
|
0.028
|
|
Cerebral vascular disease
|
0.525 (0.273–1.009)
|
0.053
|
0.841 (0.395–1.792)
|
0.654
|
|
Hypertension
|
0.528 (0.294–0.949)
|
0.033
|
1.189 (0.592–2.391)
|
0.626
|
|
Immunosuppression
|
1.653 (0.941–2.904)
|
0.081
|
0.912 (0.37–2.249)
|
0.912
|
|
Nosocomial versus CA
| | | | |
|
≤ 1
|
5.040 (1.660–15.299)
|
0.004
|
4.456 (1.405–14.135)
|
0.011
|
|
2–10
|
12.000 (1.436–100.278)
|
0.022
|
4.727 (0.494–45.221)
|
0.178
|
|
11–18
|
4.800 (0.933–24.692)
|
0.061
|
1.981 (0.327–12.001)
|
0.457
|
|
19–59
|
0.850 (0.427–1.693)
|
0.644
|
0.671 (0.312–1.442)
|
0.307
|
|
Diabetes mellitus
|
0.230 (0.097–0.544)
|
0.001
|
0.342 (0.129–0.906)
|
0.031
|
|
Hematological malignancy
|
9.475 (2.747–32.681)
|
0.000
|
4.467 (0.933–21.395)
|
0.061
|
|
Brain tumor
|
4.773 (1.016–22.427)
|
0.048
|
7.865 (1.554–39.817)
|
0.013
|
|
Immunosuppression
|
5.604 (2.197–14.291)
|
0.000
|
2.762 (0.807–9.461)
|
0.106
|
|
HCA versus CA
| | | | |
|
Diabetes mellitus
|
0.546 (0.300–0.993)
|
0.047
|
0.554 (0.288–1.067)
|
0.077
|
|
Hematological malignancy
|
3.700 (1.080–12.674)
|
0.037
|
2.62 (0.664–10.344)
|
0.169
|
|
Cerebral vascular disease
|
2.414 (1.156–5.041)
|
0.019
|
2.486 (1.154–5.356)
|
0.02
|
|
Hypertension
|
1.848 (1.003–3.404)
|
0.049
|
2.08 (1.065–4.061)
|
0.032
|
|
Immunosuppression
|
3.227 (1.309–7.954)
|
0.011
|
2.661 (0.971–7.297)
|
0.057
|
- Bold values suggest statistical significance
